China's Active Pharmaceutical Ingredients Sector Gets A Boost, the vertical B2B portal for the pharmaceutical industry, announced the launch of the virtual session CPhI China Top API Exporters & Products on 24-28 August 2020, as part of the CPhI & P-MEC China E-Trade Season.

The active pharmaceutical ingredients (API) industry in China plays a pivotal role in the global pharmaceutical ecosystem. In 2019, the Chinese API manufacturers produced and exported to the world 10.12 million tons of products, valued at $33.7 billion. With the outbreak of COVID-19, the API market has experienced some uncertainties in the beginning of 2020, yet still shows its vitality in the exporting business. In the first quarter of 2020, the total export volume of APIs of China increased by 16.68%, reaching 3.90 million tons.

"The hard time is not without opportunities, as the rising demand in health and medical global wide calls for more API supplies with higher quality," commented Zing Zhou, Senior Director of PharmaSources and CPhI China. "This event is business-intensive. It will further propel the API export Business for the Chinese players in the second half of the year."

CPhI China Top API Exporters & Products will bring together the 100 cream-of-the-crop API exporters of China and showcase the most popular exporting products, seeking to break the physical limitations, facilitate direct sourcing channels and build-up connections between global buyers and key pharma player in China.

You May Also Like

Leave a Reply

Your email address will not be published.